Revised Robert's Cytoprotection and Adaptive Cytoprotection and Stable Gastric Pentadecapeptide BPC 157. Possible Significance and Implications for Novel Mediator

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|10|1224-1234

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.10, 2010-04, pp. : 1224-1234

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stable Gastric Pentadecapeptide BPC 157: Novel Therapy in Gastrointestinal Tract

By  

Current Pharmaceutical Design, Vol. 17, Iss. 16, 2011-06 ,pp. : 1612-1632

Bentham Science Publishers

Access to resources Recommend Favorite

Toxicity by NSAIDs. Counteraction by Stable Gastric Pentadecapeptide BPC 157

By  

Current Pharmaceutical Design, Vol. 19, Iss. 1, 2013-01 ,pp. : 76-83

Bentham Science Publishers

Access to resources Recommend Favorite

Focus on Ulcerative Colitis: Stable Gastric Pentadecapeptide BPC 157

By  

Current Medicinal Chemistry, Vol. 19, Iss. 1, 2012-01 ,pp. : 126-132

Bentham Science Publishers

Access to resources Recommend Favorite

Stable Gastric Pentadecapeptide BPC 157-NO-system Relation

By  

Current Pharmaceutical Design, Vol. 20, Iss. 7, 2014-02 ,pp. : 1126-1135

Bentham Science Publishers

Access to resources Recommend Favorite

Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications

By  

Current Neuropharmacology, Vol. 14, Iss. 8, 2016-11 ,pp. : 857-865

Bentham Science Publishers

Access to resources Recommend Favorite